C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile
C. Michael Gibson MD

@cmichaelgibson

Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor clinicaltrialresults.org | RT ≠ endorse | Disclaimer: bit.ly/1mewZOF

ID: 879161563

linkhttp://www.linkedin.com/in/cmichaelgibson calendar_today14-10-2012 02:33:11

85,85K Tweet

437,437K Followers

372,372K Following

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo
C. Michael Gibson MD
@cmichaelgibson

5 months ago

In DEDICATE-DZHK6 trial for low/intermediate surgical risk and severe symptomatic AS, risk of all-cause death or stroke was non-inferior in TAVR (using any contemporary device) vs. SAVR. Download trial slides here: shorturl.at/kyAW4

In DEDICATE-DZHK6 trial for low/intermediate surgical risk and severe symptomatic AS, risk of all-cause death or stroke was non-inferior in TAVR (using any contemporary device) vs. SAVR. Download trial slides here: shorturl.at/kyAW4